Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
Less is more: patent lawyers flip the script after Amgen
Americas
Less is more: patent lawyers flip the script after Amgen
The Supreme Court’s 2023 Amgen ruling turned patent strategy upside down. Now lawyers are rethinking everything they thought they knew about protecting inventions. Marisa Woutersen reports from LSPN North America–Fall.   22 October 2025
‘Doing more with less’: In-house counsel on budgets and strategy
Biotech
‘Doing more with less’: In-house counsel on budgets and strategy
Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.   22 October 2025
As investment in UK life sciences wanes, is the sector in trouble?
Europe
As investment in UK life sciences wanes, is the sector in trouble?
As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.   14 October 2025
Europe
Bridging Brunel and AI: Why CIPA sees ‘a golden opportunity’
The promises and pitfalls of AI took centre stage at CIPA’s annual congress in Bristol this week, as Sarah Speight reports.   9 October 2025
Americas
Eli Lilly strikes AI drug discovery deal with US biotech
The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks.   7 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
From stalled drug approvals to suspended patent investigations, US rightsholders face mounting uncertainty during the federal freeze.   2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.   1 October 2025
Americas
Philips wins 'unheard of' trade secret sanctions against Chinese defendants
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners.   1 October 2025
Americas
Biotech sues AstraZeneca and Cellectis over mRNA patents
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals.   29 September 2025
Europe
EU court delivers verdict on Biogen’s market exclusivity for MS drug
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug Tecfidera.   25 September 2025